Ocugen IncOCGN shares are trading higher by 23.8% at $4.28 Tuesday morning after the company announced the FDA lifted its clinical hold on the company’s COVID-19 vaccine study in the US.
“We are pleased to be able to move our clinical program for Covaxin forward, which we hope will bring us closer to offering an alternative Covid-19 vaccine,” said Dr. Shankar Musunuri, CEO of Ocugen. “We firmly believe that managing this pandemic requires more than one approach to vaccines, so we are heartened to be able to continue developing our vaccine candidate.”
Ocugen will also discuss its fourth-quarter and full-year 2021 financial results and provide a business update at 8:30 a.m. ET on Friday, February 25.
Ocugen is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases.
Ocugen has a 52-week high of $17.65 and a 52-week low of $2.87.
If you are not using this trading strategy, you are leaving money on the table…
If you are blindly looking up and trading stocks the way 99% of traders are, you are missing on HUGE potential returns. Even new traders who started following this option trading strategy instantly began seeing returns they wouldn’t have had otherwise. With even two trades per month with this strategy, you will start seeing the difference in your trading account. Don’t waste any more time “guessing” and “getting lucky”. Click Here to See if you Qualify for Benzinga Options!
For today only, we are gifting away our Benzinga Options Starter newsletter for a massive 40% OFF. This includes two heavily researched trades per month from lead trader, Nic Chahine. For the same cost of a cup of coffee, less than the cost of a Netflix subscription, and less than the average order at McDonalds each month you will receive top-tier education and winning trade alerts to maximize your portfolio returns. This also includes a 14-day full money-back guarantee if you cancel. There is absolutely no risk! Click Here Now to Get Started!Â
Download and distribute powerful vaccination QI resources for your community.
Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
Medicare
Discover an honest look at our Medicare system.
Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
